Showing results (231-240 of 251) with videos related to
Sort By:
Pageof 26
International Journal of Stroke : Official Journal of the International Stroke Society|November 19, 2024
Transient brain ischemic symptoms and the presence of ischemic lesions at neuroimaging: Results from the READAPT studyRaffaele Ornello, Matteo Foschi, Federico De Santis, et al.Journal of the American Heart Association|August 9, 2024
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study CohortRaffaele Ornello, Matteo Foschi, Federico De Santis, et al.Journal of the Neurological Sciences|September 8, 2024
Defining short-term outcomes of minor ischemic stroke due to small artery occlusion in the era of dual antiplatelet treatment: A READAPT study sub-analysisMatteo Foschi, Eleonora De Matteis, Federico De Santis, et al.European Stroke Journal|June 13, 2024
Beyond RCTs: Short-term dual antiplatelet therapy in secondary prevention of ischemic stroke and transient ischemic attackEleonora De Matteis, Raffaele Ornello, Federico De Santis, et al.Therapeutic Advances in Neurological Disorders|July 15, 2025
Real-world outcomes following dual antiplatelet therapy in mild-to-moderate ischemic stroke with anterior versus posterior circulation infarct: a READAPT study propensity matched analysisFederico De Santis, Raffaele Ornello, Eleonora De Matteis, et al.European Stroke Journal|April 23, 2025
Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT studyMatteo Foschi, Federico De Santis, Lucio D'Anna, et al.Stroke|December 9, 2024
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study CohortMatteo Foschi, Lucio D'Anna, Eleonora De Matteis, et al.JAMA Network Open|April 28, 2026
Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough StrokeLucio D'Anna, Francesca Gabriele, Raffaele Ornello, et al.Journal of the Neurological Sciences|August 7, 2025
Characteristics and causes of recurrent ischemic events in minor ischemic stroke and TIA in the READAPT studyFederico De Santis, Matteo Foschi, Michele Romoli, et al.European Stroke Journal|February 27, 2026
Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R studyMatteo Foschi, Federico De Santis, Francesca Gabriele, et al.Pageof 26